Target Name: SENP5
NCBI ID: G205564
Review Report on SENP5 Target / Biomarker Content of Review Report on SENP5 Target / Biomarker
SENP5
Other Name(s): FLJ42398 | Sentrin-specific protease 5 | SENP5 variant 1 | Sentrin/SUMO-specific protease SENP5 | SUMO1/sentrin specific protease 5 | Sentrin-specific protease 5 (isoform 1) | MGC27076 | SUMO1/sentrin specific peptidase 5 | SUMO specific peptidase 5, transcript variant 1 | DKFZp564O1016 | SENP5_HUMAN | SUMO specific peptidase 5 | sentrin/SUMO-specific protease SENP5

SENP5: Potential Drug & Biomarker

SENP5 (FLJ42398) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the SENP family of proteins, which are known for their role in DNA repair and other cellular processes. SENP5 has been shown to be involved in a number of cellular processes, including cell division, apoptosis, and inflammation.

One of the unique features of SENP5 is its ability to interact with other proteins that are involved in the DNA damage response. This interaction is important for the regulation of DNA repair and cell survival, as damage to DNA can lead to the development of cancer. SENP5 has been shown to play a role in the repair of DNA damage caused by various types of stress, including radiation and chemicals.

In addition to its role in the DNA damage response, SENP5 has also been shown to be involved in a number of other cellular processes. For example, it has been shown to play a role in the regulation of cell growth and differentiation, as well as in the development of neurodegenerative diseases. SENP5 has also been shown to be involved in the regulation of inflammation, both at the level of systemic inflammation and in the regulation of immune responses.

SENP5 is also a potential drug target. Its role in a number of cellular processes makes it an attractive target for the development of new treatments for a variety of diseases. For example, SENP5 has been shown to be involved in the regulation of the DNA damage response, which is a key factor in the development of cancer. By targeting the DNA damage response pathway, new treatments may be able to inhibit the growth and spread of cancer cells.

In addition to its potential as a drug target, SENP5 is also a potential biomarker. Its role in a number of cellular processes makes it an attractive target for the development of new diagnostic tests for a variety of diseases. For example, SENP5 has been shown to be involved in the regulation of the DNA damage response, which can be used as a marker for the detection of DNA damage in cancer cells.

Overall, SENP5 is a protein that has the potential to be a drug target and a biomarker. Its role in the regulation of the DNA damage response and its involvement in a number of cellular processes make it an attractive target for the development of new treatments and diagnostic tests for a variety of diseases. Further research is needed to fully understand the role of SENP5 in these processes and its potential as a drug and biomarker.

Protein Name: SUMO Specific Peptidase 5

Functions: Protease that catalyzes two essential functions in the SUMO pathway: processing of full-length SUMO3 to its mature form and deconjugation of SUMO2 and SUMO3 from targeted proteins. Has weak proteolytic activity against full-length SUMO1 or SUMO1 conjugates. Required for cell division

The "SENP5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SENP5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SENP6 | SENP7 | SENP8 | SEPHS1 | SEPHS1P4 | SEPHS1P6 | SEPHS2 | SEPSECS | SEPSECS-AS1 | SEPT5-GP1BB | SEPTIN1 | SEPTIN10 | SEPTIN11 | SEPTIN12 | SEPTIN14 | SEPTIN2 | SEPTIN3 | SEPTIN4 | SEPTIN4-AS1 | SEPTIN5 | SEPTIN6 | SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3 | SERTAD4 | SERTAD4-AS1 | SERTM1 | SERTM2 | Serum amyloid protein | SESN1 | SESN2 | SESN3